Table 2.
Study | N | Population description | Internal consistency: Cronbach’s alpha | Test-retest reliability: ICC | Comparator | Correlation |
---|---|---|---|---|---|---|
Bellamy et al 19885 | 57 | People from Canada with knee or hip OA who were taking part in a randomized controlled trial of 2 nonsteroidal anti-inflammatory drugs | Likert Scale format = 0.95. VAS format = 0.89 |
Lequesne Physical Function | r = 0.5 | |
Xie et al 200841 | 131 | People from Singapore, China with knee OA scheduled for TKA | > 0.7 | > 0.8 | SF-36 physical functioning and EQ-5D in Chinese and English | r > 0.5 |
Nadrian et al 201242 | 116 | People from Iran with physician diagnosed referred to a rheumatology clinic with knee or hip OA | 0.95 | > 0.7 | Lequesne Physical Function | r > 0.5 |
Thumboo et al 200143 | 66 | English-speaking Chinese, Malay or Indian people with knee or hip OA seen at a tertiary referral center | 0.93 | > 0.8 | SF-36 Physical Functioning | r = −0.4 |
Tüzün, et al., 200519 | 72 | People from Turkey being seen in an outpatient physical therapy practice with knee OA | 0.94 | SF-36 Physical Functioning, Lequesne Physical Function | r = −0.7, r = 0.7 | |
Basaran, et al., 201044 | 117 | People from Turkey with knee or hip OA | 0.95 | SF-36 Physical Functioning | r = −0.8 | |
Williams et al 201245 | 168 | People with knee OA participating in a rehabilitation program. | > 0.8 |